Abstract:To investigate the associated biomolecular mechanisms of intratumoral RFH- enhanced local HSV-TK/ ganciclovir (GCV)-mediated suicide gene therapy of rat orthotopic lung cancers. Human lung cancer cells (A549) transduced with Luciferase/mCherry/lentivirus and 24 nude rats with orthotopic lung cancers were divided into four study groups with treatments of (i) intratumoral HSV-TK/GCV gene therapy followed by RFH at 41-42 °C for 30 minutes; (ii) HSV-TK/GCV therapy alone; (iii) RFH alone; (iv) PBS as a control. Flow cytometry, bioluminescence assay and confocal microscopy were used to determine the apoptosis and viability of cells. Bioluminescence optical imaging was used to evaluate the changes of bioluminescent signals among the groups over 2 weeks. The expression of Bcl-2/Bax, Caspase-3 and HSP70 in both cells and tumor tissue were quantified by western blotting (WB) and immunohistochemistical (IHC) staining respectively. Compared with gene therapy alone, RFH alone or PBS, combination therapy induced the lowest cell viability (30.56 ± 9.12% VS 65.47 ± 8.02% VS 89.95 ± 6.33% VS 100% P<0.05), the highest cell apoptosis (20.05 ± 2.12% VS 9.87 ± 2.02% VS 4.31 ± 4.31% VS 3.12 ± 1.03%, P<0.05), and a remarkable decrease of relative bioluminescence signal (16.54 ± 0.12% VS 54.8 ± 0.10% VS 85.01 ± 0.08% VS 100%, P<0.01). Optical imaging showed a markedly decreased bioluminescence signal of the tumor in combination therapy (1.29 ± 0.18 VS 1.76 ± 0.13 VS 2.26 ± 0.17 VS 2.94 ± 0.15, P<0.05). Both WB analysis and IHC staining displayed the significantly decreased expression of Bcl-2 (1.03 ± 0.28 VS 2.15 ± 0.33 VS 3.48 ± 0.12 VS 3.87 ± 0.17×107 IOD, P<0.01), as well as increased expression of Bax (3.30 ± 0.0.36 VS 2.02 ± 0.20 VS 1.48 ± 0.31 VS 1.26 ± 0.07, 107 IOD, P<0.01), Caspase-3 (5.58 ± 0.52 VS 3.36 ± 0.29 VS 1.42 ± 0.34VS 1.21 ± 0.52, 107 IOD, P<0.05) and HSP70 (8.79 ± 0.62 VS 3.97 ± 0.31 VS 4.48 ± 0.42 VS 1.60 ± 0.23, 107 IOD, P<0.01) in cancer tissues of combination therapy group. Intratumoral RFH-enhanced suicide gene therapy on rat orthotopic lung cancers through the mechanisms of augmenting apoptosis and the expression of HSP-70 pathway, which may provide additional insights to further improving treatment of lung cancers.

Overexpression of Ras-Related C3 Botulinum Toxin Substrate 2 Radiosensitizes Melanoma Cells In Vitro and In Vivo

Co-Inhibition Of Glut-1 Expression And The Pi3k/Akt Signaling Pathway To Enhance The Radiosensitivity Of Laryngeal Carcinoma Xenografts In Vivo

The Effect of RAC2 on Radiosensitivity of Melanoma Cells

Harnessing the Power of Kiwifruit for Radiosensitization of Melanoma

Rgd-Conjugated Gold Nanorods Induce Radiosensitization in Melanoma Cancer Cells by Downregulating Alpha(V)Beta(3) Expression

4:10 PM Abstract No. 50 Intratumoral Radiofrequency Hyperthermia-Enhanced Herpes Simplex Virus Thymidine Kinase (HSV-TK) Gene Therapy of Orthotopic Lung Cancer Through the Augmentation of Apoptosis and Heat Shock Protein (HSP70) Expression Pathway

2-Methoxyestradiol Enhances Radiosensitivity in Radioresistant Melanoma MDA-MB-435R Cells by Regulating Glycolysis Via HIF-1α/PDK1 Axis

The Radiosensitization of Melanoma Cells by Gold Nanorods Irradiated with MV X-ray

Mesoporous Bi-Containing Radiosensitizer Loading with DOX to Repolarize Tumor-Associated Macrophages and Elicit Immunogenic Tumor Cell Death to Inhibit Tumor Progression.

Targeted Alpha-Particle Radiotherapy and Immune Checkpoint Inhibitors Induces Cooperative Inhibition on Tumor Growth of Malignant Melanoma

Ras-Targeting Stabilized Peptide Increases Radiation Sensitivity of Cancer Cells

Ctc1 Increases The Radioresistance Of Human Melanoma Cells By Inhibiting Telomere Shortening And Apoptosis

Strategy to enhance the anticancer efficacy of X-ray radiotherapy in melanoma cells by platinum complexes, the role of ROS-mediated signaling pathways.

MicroR-545 Enhanced Radiosensitivity Via Suppressing Ku70 Expression in Lewis Lung Carcinoma Xenograft Model

Single-Cell Profiling Reveals Immune-Based Mechanisms Underlying Tumor Radiosensitization by a Novel Mn Porphyrin Clinical Candidate, MnTnBuOE-2-PyP5+ (BMX-001)

Carbon ion radiotherapy triggers immunogenic cell death and sensitizes melanoma to anti-PD-1 therapy in mice

UBE2C Mediated Radiotherapy Resistance of Head and Neck Squamous Cell Carcinoma by Regulating Oxidative-Stress-relative Apoptosis.

Radiation combined with KRAS-MEK inhibitors enhances anticancer immunity in KRAS-mutated tumor models

Sensitization of Cancer Cells to Radiation by Selenadiazole Derivatives by Regulation of ROS-mediated DNA Damage and ERK and AKT Pathways.

Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanoma

Inhibiting the CD8+ T Cell Infiltration in the Tumor Microenvironment after Radiotherapy is an Important Mechanism of Radioresistance